UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

The Lancet (British edition), 2021-02, Vol.397 (10274), p.592-604

2021

Volltextzugriff (PDF)

Successful retreatment with erlotinib after erlotinib-related interstitial lung disease

Tumori, 2021-12, Vol.107 (6), p.NP84-NP86

2021

Volltextzugriff (PDF)

Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2024-05, Vol.27 (3), p.558-570

2024

Volltextzugriff (PDF)

Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study

The lancet oncology, 2022-11, Vol.23 (11), p.1430-1440

2022

Volltextzugriff (PDF)

Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram

Supportive care in cancer, 2024-08, Vol.32 (8), p.492, Article 492

2024

Volltextzugriff (PDF)

Comparison of different decision support software programs in perspective of potential drug–drug interactions in the oncology clinic

Journal of oncology pharmacy practice, 2023-07, Vol.29 (5), p.1178-1186

2023

Volltextzugriff (PDF)

Assessment of cyclin D1 activity in tumors and tumor budding and its prognostic significance in tumor budding in colorectal carcinomas

Indian journal of pathology & microbiology, 2024-06

2024

Volltextzugriff (PDF)

Diffusion Tensor Imaging Can Discriminate the Primary Cell Type of Intracranial Metastases for Patients with Lung Cancer

Magnetic Resonance in Medical Sciences, 2022, Vol.21(3), pp.425-431

2022

Volltextzugriff (PDF)

A comparison of anticholinergic burden in older patients with and without cancer

Future oncology (London, England), 2021-12, Vol.17 (36), p.5067-5075

2021

Volltextzugriff (PDF)

Stem cell markers: A guide to neoadjuvant therapy in breast carcinomas

Indian journal of pathology & microbiology, 2023-07, Vol.66 (3), p.495-501, Article 495

2023

Volltextzugriff (PDF)

Evaluation of toxic effects of chemotherapy in lung malignancies on cerebral white matter using diffusion tensor imaging

Radiology and oncology, 2022-05, Vol.56 (2), p.150-155

2022

Volltextzugriff (PDF)

Anxiety levels of breast cancer patients in Turkey during the COVID-19 pandemic

Future oncology (London, England), 2021-09, Vol.17 (25), p.3373-3381

2021

Volltextzugriff (PDF)

Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study

Future oncology (London, England), 2022-03, Vol.18 (10), p.1235-1244

2022

Volltextzugriff (PDF)

The efficacy of BNT162b2 (Pfizer–BioNTech) and CoronaVac vaccines in patients with cancer

Journal of medical virology, 2022-09, Vol.94 (9), p.4138-4143

2022

Volltextzugriff (PDF)

Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary study

European journal of radiology, 2020-04, Vol.125, p.108895-108895, Article 108895

2020

Volltextzugriff (PDF)

Surprise diagnosis in an adolescent case with chronic kidney damage: Answers

Pediatric nephrology (Berlin, West), 2021-07, Vol.36 (7), p.1997-1999

2021

Volltextzugriff (PDF)

Surprise diagnosis in an adolescent case with chronic kidney damage: Questions

Pediatric nephrology (Berlin, West), 2021-07, Vol.36 (7), p.1995-1996

2021

Volltextzugriff (PDF)

A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer

Journal of oncology pharmacy practice, 2022-01, Vol.28 (1), p.242-246

2022

Volltextzugriff (PDF)

Differentiation of lung and breast cancer brain metastases: Comparison of texture analysis and deep convolutional neural networks

Journal of clinical ultrasound, 2023-11, Vol.51 (9), p.1579-1586

2023

Volltextzugriff (PDF)

Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases

Scientific reports, 2024-03, Vol.14 (1), p.5820-5820, Article 5820

2024

Volltextzugriff (PDF)

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

Journal of oncology pharmacy practice, 2024-04, p.10781552241241004-10781552241241004

2024

Volltextzugriff (PDF)

The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma

Bosnian journal of basic medical sciences, 2022-11, Vol.22 (6), p.982-991

2022

Volltextzugriff (PDF)

Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?

Current problems in cancer, 2021-02, Vol.45 (1), p.100619-100619, Article 100619

2021

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(62)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Successful retreatment with erlotinib after erlotinib-related interstitial lung disease

Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial

Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study

Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram

Patient‐reported outcomes with cemiplimab monotherapy for first‐line treatment of advanced non–small cell lung cancer with PD‐L1 of ≥50%: The EMPOWER‐Lung 1 study

Comparison of different decision support software programs in perspective of potential drug–drug interactions in the oncology clinic

Assessment of cyclin D1 activity in tumors and tumor budding and its prognostic significance in tumor budding in colorectal carcinomas

Diffusion Tensor Imaging Can Discriminate the Primary Cell Type of Intracranial Metastases for Patients with Lung Cancer

A comparison of anticholinergic burden in older patients with and without cancer

Stem cell markers: A guide to neoadjuvant therapy in breast carcinomas

Evaluation of toxic effects of chemotherapy in lung malignancies on cerebral white matter using diffusion tensor imaging

Anxiety levels of breast cancer patients in Turkey during the COVID-19 pandemic

Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study

The efficacy of BNT162b2 (Pfizer–BioNTech) and CoronaVac vaccines in patients with cancer

Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary study

Surprise diagnosis in an adolescent case with chronic kidney damage: Answers

Surprise diagnosis in an adolescent case with chronic kidney damage: Questions

A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer

Differentiation of lung and breast cancer brain metastases: Comparison of texture analysis and deep convolutional neural networks

A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study

Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases

Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC

The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma

Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?

Aktive Filter

Suchergebnisse filtern